News for Compugen Ltd. (CGEN.TA)

Published at

Mar 23, 2025 1:29 PM

by insidermonkey.com

neutral

neutral

Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are going to take a look at where Compugen Ltd.

CGEN.TA CGEN

Read more →
Published at

Mar 22, 2025 7:50 PM

by insidermonkey.com

neutral

neutral

10 Penny Stocks With Huge Upside Potential According To Analysts

Penny stocks trade below $5 and attract investors looking for high returns with a small initial investment.

CGEN.TA CGEN

Read more →
Published at

Mar 5, 2025 2:13 PM

by insidermonkey.com

positive

positive

Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Fourth Quarter and Full Year 2024 Results Conference Call.

CGEN.TA CGEN

Read more →
Published at

Mar 5, 2025 6:03 AM

by gurufocus.com

positive

positive

Q4 2024 Compugen Ltd Earnings Call Transcript

Mar 04, 2025 / 01:30PM GMTOperator Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's fourth-quarter and full-year 2024 results confere

CGEN.TA CGEN

Read more →
Published at

Mar 4, 2025 4:34 PM

by seekingalpha.com

neutral

neutral

Compugen Ltd. (CGEN) Q4 2024 Earnings Call Transcript

Compugen Ltd. (NASDAQ:CGEN) Q4 2024 - Earnings Conference Call March 4, 2025 8:30 AM ETCompany ParticipantsYvonne Naughton - VP, Head of IR and Corporate...

CGEN.TA CGEN

Read more →
Published at

Mar 4, 2025 3:00 PM

by gurufocus.com

neutral

neutral

/C O R R E C T I O N -- Compugen Ltd./

PR NewswireHOLON, Israel, March 4, 2025 In the news release, Compugen Reports Fourth Quarter and Full Year 2024 Results, issued 04-Mar-2025 by Compugen Ltd

CGEN.TA CGEN AZN

Read more →
Published at

Mar 4, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Compugen Reports Fourth Quarter and Full Year 2024 Results

PR NewswireHOLON, Israel, March 4, 2025 Clinical data presented at SITC 2024 supports further development of COM701, potential first-in-class anti-PVRIG an

CGEN.TA CGEN AZN

Read more →
Published at

Mar 3, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference

PR NewswireHOLON, ISRAEL, March 3, 2025 HOLON, ISRAEL , March 3, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer im

CGEN.TA AZN CGEN

Read more →
Published at

Feb 26, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology

PR NewswireHOLON, Israel, Feb. 26, 2025 Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Un

CGEN.TA AZN CGEN

Read more →
Published at

Feb 18, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Compugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025

PR NewswireHOLON, Israel, Feb. 18, 2025 HOLON, Israel, Feb. 18, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immu

AZN CGEN.TA CGEN

Read more →
Published at

Feb 3, 2025 6:38 PM

by investopedia.com

mixed

mixed

Best Penny Stocks to Watch in February 2025

This is our list of the best penny stocks to watch, based on a review of stocks that had positive performance over the last 30 days.

ATAI SHCAF COMP CMPX CMPGY CMPGF BRKO TTI CGEN.TA CGEN BTCSD BTCS

Read more →
Published at

Dec 6, 2024 9:50 PM

by gurufocus.com

positive

positive

Compugen (CGEN) Stock Surges Amid Biotech Industry Movement

Compugen Ltd (CGEN), a clinical-stage therapeutic discovery and development company, saw its stock rise by 5% to $1.66 with a trading volume of 315,350 shares.

CGEN.TA CGEN ADCT

Read more →
Published at

Nov 27, 2024 2:00 PM

by gurufocus.com

mixed

mixed

Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies

PR NewswireHOLON, Israel, Nov. 27, 2024 Broad method of use patent protection for COM902, a potential best-in-class reduced Fc, clinical stage, anti-TIGIT

AZN CGEN.TA CGEN

Read more →
Published at

Nov 22, 2024 9:30 PM

by gurufocus.com

mixed

mixed

Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements

Compugen Ltd. (CGEN), a clinical-stage therapeutic discovery and development company, recently experienced a significant stock fluctuation with a 5.17% drop in

XCUR VRPX REPL RCKT CGEN.TA CGEN MTEM

Read more →
Published at

Nov 12, 2024 9:35 PM

by seekingalpha.com

neutral

neutral

Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript

Start Time: 08:30 January 1, 0000 9:30 AM ETCompugen Ltd.

CGEN.TA CGEN

Read more →
Published at

Nov 8, 2024 10:00 AM

by medium.com

mixed

mixed

Top Companies In The Bioinformatics Market

The Bioinformatics Market Size sector reached a market value of USD 20.72 Billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 17.6% from 2023 to…

CGEN.TA CGEN TMO.MX TMO ILU.DE ILMN.MX ILMN I1LM34.SA A1GI34.SA A.MX A

Read more →
Published at

Oct 30, 2024 6:28 PM

by investing.com

mixed

mixed

Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer By Investing.com

Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer

ITT SKXJF MRK CGEN.TA CGEN AZN.L AZN 6417.T 0A4J.L SEER 0IJU.L

Read more →
Published at

Oct 9, 2024 8:23 PM

by gurufocus.com

positive

positive

Q2 2024 Compugen Ltd Earnings Call Transcript

Aug 06, 2024 / 12:30PM GMTOperator Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's second quarter 2024 Results conference call. At t

CGEN.TA CGEN

Read more →
Published at

Aug 10, 2024 11:54 AM

by seekingalpha.com

neutral

neutral

Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript

Compugen Ltd. (NASDAQ:NASDAQ:CGEN) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ETCompany ParticipantsYvonne Naughton - Head of Investor...

CGEN.TA CGEN

Read more →
Published at

Jul 18, 2024 9:37 PM

by benzinga.com

mixed

mixed

Alterity Up on Interim Data From Advance MSA Study - Compugen (NASDAQ:CGEN), Alterity Therapeutics (NASDAQ:ATHE)

Shares of Alterity Therapeutics (NASDAQ: ATHE) were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for treating patients with multiple system atrophy, a rare neurodegenerative disease.

XAIR CGEN.TA ATHE CGEN

Read more →